Cognition and Cancer
Cambridge University Press, 12/13/2012
EAN 9781107411814, ISBN10: 1107411815
Paperback, 356 pages, 24.6 x 18.8 x 2 cm
Language: English
Most people afflicted by cancer will experience cognitive impairment, sometimes referred to as 'chemobrain' or 'chemofog', due to the various direct and indirect effects of their disease and its treatment. In addition, patients with primary or metastatic tumors of the brain experience direct neurologic symptoms due, for example, to the location of their disease, surgical intervention, and the late effects of treatment such as radiotherapy. The aim of this book is to serve as a resource for health care professionals working with cancer patients who experience cognitive changes as a result of their cancer and its treatment. It provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions.
Preface
List of contributors
Part I. Cognition and the Brain
Measurement, Tools, and Interpretation
1. Introduction Christina A. Meyers and James R. Perry
2. Clinical neuropsychology Jill B. Rich and Angela K. Troyer
3. Brain imaging investigation of chemotherapy-induced neurocognitive changes Brenna C. McDonald, Andrew J. Saykin and Tim A. Ahles
4. Role of neuropsychological assessment in cancer patients Elana Farace
5. Neuropsychological assessment of adults with cancer Anne E. Kayl, Robert Collins, and Jeffrey S. Wefel
6. Neuropsychological assessment of children with cancer Louise Penkman Fennell and Robert W. Butler
Part II. Effects of Cancer and Cancer Treatment on Cognition
7. Biological bases of radiation injury to the brain Edward G. Shaw and Mike E. Robbins
8. Chemotherapy and biological response modifier-related cognitive dysfunction Jeffrey S. Wefel, Robert Collins and Anne E. Kayl
9. Effect of hormones and hormonal treatment on cognition Christien Schilder, Sanne Schagen and Frits van Dam
10. Low grade gliomas Martin J. B. Taphoorn and Charles G. Niel
11. High grade gliomas Michael J. Glantz and James R. Perry
12. Brain metastases Deepak Khuntia, Beela S. Mathew, Christina A. Meyers, Sterling Johnson and Minesh P. Mehta
13. Primary Central Nervous System lymphoma Denise D. Correa
14. Childhood brain tumors H. Stacy Nicholson, Louise Penkman Fennell and Robert W. Butler
15. Neurofibromatosis Bartlett D. Moore, III and John M. Slopis
16. Hematological malignancies Melissa Friedman and Mercedes Fernandez
17. Paraneoplastic disorders Edward Dropcho
18. Symptomatic therapies and supportive care issues Alan Valentine and Eduardo Bruera
19. Animal models and cancer related symptoms Adrian Dunn
Part III. Interventions and Implications for Clinical Trials
20. Behavioral strategies and rehabilitation Dona E. C. Locke, Jane H. Cerhan and James F. Malec
21. Support services Bebe Guill and Renee H. Raynor
22. Pharmacologic interventions for the treatment of radiation-induced brain injury Edward G. Shaw, Jerome Butler, L. Douglas Case, Ralph d'Agostino, Jr., John Gleason, Jr., Edward Ip, Mike E. Robbins, Paul Saconn and Stephen R. Rapp
23. Neurocognitive testing in clinical trials Jennifer A. Smith and Jeffrey S. Wefel.